Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted a quarterly certificate from its Registrar and Share Transfer Agent (RTA), M/s Venture Capital and Corporate Investments Pvt Ltd, for the quarter ended September 30, 2025. The certificate confirms that all physical shares received for dematerialization have been properly cancelled after verification, and the records have been updated to show NSDL and CDSL as the registered owners within the required 15-day timeline. Details of the dematerialized securities have also been shared with the stock exchanges. This is a routine compliance submission under SEBI's depository regulations, filed on October 8, 2025.
This is a standard procedural compliance filing and has no material impact on the company's financials, operations, or stock price. No action required from shareholders.